CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
171204-20-9 | | 2-(4-pyridinylamino)-4-quinolinecarboxylic aci | | | | |
171204-21-0 | | 1,2-dihydro-n-(3-methylbutyl)-2-oxo-4-quinolinecarboxylic aci | | | | |
171204-22-1 | | 1,2-dihydro-n-(2-methylphenyl)-2-oxo-4-quinolinecarboxamid | | | | |
171204-23-2 | | 1,2-dihydro-n-(2,4-dimethylphenyl)-2-oxo-4-quinolinecarboxamid | | | | |
17121-12-9 | 偏磷酸盐 | metaphosphate | | | | |
17121-19-6 | dd -2,6-二氨基庚二酸 | dd-2,6-diaminopimelic acid | | | | |
17121-34-5 | | 2-propanol, 1,1',1'',1'''-[[(2-hydroxypropyl)imino]bis(2,1-ethanediylnitrilo)]t | C19H43N3O5 | 393.57 | | |
17122-21-3 | | 1-nitro-3-nitrosobenzene | | | | |
17122-55-3 | | (2e)-n-(3-chlorophenyl)-2-(hydroxyimino)ethanamide | | | | |
17122-58-6 | | N1-(2,5-dichlorophenyl)-2-hydroxyiminoacetamide | C8H6Cl2N2O2 | | | |
17122-69-9 | | 2-(hydroxyimino)-3',4'-dimethylacetanilide | | | | |
17122-70-2 | | (2z)-n-(4-ethylphenyl)-2-(hydroxyimino)acetamide | | | | |
17122-95-1 | | 1,8-Dichloro-10-methylanthracene | C15H10Cl2 | 261.15 | | |
17122-96-2 | | 1,8-Dichloro-9-methylanthracene | C15H10Cl2 | 261.15 | | |
171228-49-2 | 泊沙康唑 | posaconazole | C37H42F2N8O4 | 700.78 | 170-172 ℃ | 850.7ºC at 760 mmHg |
171228-50-5 | 泊沙康唑杂质21 | posaconazole impurity 21 | | | | |
171228-51-6 | 泊沙康唑杂质17 | posaconazole impurity 17 | | | | |
17123-20-5 | | 2,5-bis(4-methylanilino)-3,6-dichloro-1,4-benzoquinone | | | | |
17123-21-6 | | 2,5-bis(4-methoxyanilino)-3,6-dichloro-1,4-benzoquinone | | | | |
17123-28-3 | | sarcosyl-l-phenylalanine | | | | |
17123-30-7 | | gly-phe-ala | C14H19N3O4 | 293.32 | | |
17123-43-2 | | sodium dihydroxyethylglycine | | | | |
17123-60-3 | | 2-methyl-1,5-hexadien-3-ol | | | | |
17123-63-6 | 2,5-二甲基-1,5-己二烯-3-醇 | 2,5-dimethyl-1,5-hexadien-3-ol | | | | |
17123-74-9 | | o-hydroxy-hydrocinnamic aci acetate | C11H12O4 | 208.21 | | |
17123-82-9 | | 1-(3-(4-chlorophenyl)-1-oxo-2-propenyl)-piperidin | | | | |
171230-55-0 | | doyle dirhodium catalyst - rh2(4S-mppim)4 | C60H66N10O16Rh2 | 1389.05 | | |
171230-81-2 | (R)-2-((叔丁基二甲基甲硅烷基)氧基)丙酸甲酯 | (R)-methyl 2-((tert-butyldimethylsilyl)oxy)propanoate | C10H22O3Si | 218.37 | | |
171235-71-5 | | tapi-1(random configuration) | C26H37N5O5 | 499.6 | | |
171237-36-8 | | hepatic leukemia factor | | | | |
17124-24-2 | | n(6)-methoxyadenine | | | | |
17124-29-7 | | (o-phenylenebis(oxy-2-butynylene))bis(trimethyl-ammoniu diiodide | | | | |
17124-30-0 | | (o-phenylenebis(oxy-2-butynylene))bis(diethylmethyl-ammoniu diiodide | | | | |
17124-31-1 | | (o-phenylenebis(oxy-2-butynylene))bis(triethyl-ammoniu diiodide | | | | |
17124-32-2 | | (p-phenylenebis(oxy-2-butynylene))bis(ethyldimethyl-ammoniu diiodide | | | | |
17124-33-3 | | (m-phenylenebis(oxy-2-butynylene))bis(diethylmethyl-ammoniu diiodide | | | | |
17124-34-4 | | (p-phenylenebis(oxy-2-butynylene))bis(trimethyl-ammoniu diiodide | | | | |
17124-35-5 | | (m-phenylenebis(oxy-2-butynylene))bis(ethyldimethyl-ammoniu diiodide | | | | |
17124-36-6 | | (p-phenylenebis(oxy-2-butynylene))bis(diethylmethyl-ammoniu diiodide | | | | |
17124-37-7 | | (p-phenylenebis(oxy-2-butynylene))bis(triethyl-ammoniu diiodide | | | | |
17124-56-0 | | 3-(6-chloro-2-oxo-benzooxazol-3-yl)-propionic acid | | | | |
17124-68-4 | | 2-(2-aminoethyl)-1,3-dimethyl-2-thio-pseudoure dihydrobromide | | | | |
17124-71-9 | | 2-(2-aminoethyl)-1-(1-naphthyl)-2-thio-pseudoure dihydrobromide | | | | |
17124-73-1 | | 2-(2-(diethylamino)ethyl)-2-thio-pseudoure dihydrochloride | | | | |
17124-74-2 | | 2-(2-(diethylamino)ethyl)-1-phenyl-2-thio-pseudoure dihydrobromide | | | | |
17124-75-3 | | 2-((2-(diethylamino)ethyl)thio)-2-imidazolin dihydrochloride | | | | |
17124-80-0 | | 2-(1 h -benzoimidazol-2-ylsulfanyl)-ethylamine | | | | |
17124-82-2 | | | | | | |
171243-30-4 | 3-氟-5-(三氟甲基)苯甲酰氯 | 3-fluoro-5-(trifluoromethyl)benzoyl chloride | C8H3ClF4O | 226.56 | | 119℃ |
1712454-96-0 | 4', 4''', 4''''', 4'''''''-(乙烯-1, 1, 2, 2-四基)四(([1, 1'-联苯]-4-醇)) | 4', 4''', 4''''', 4'''''''-(Ethene-1, 1, 2, 2-tetrayl)tetrakis(([1, 1'-biphenyl]-4-ol)) | C50H36O4 | 700.82 | | |